101 related articles for article (PubMed ID: 2804889)
1. Evaluation of serum levels of soluble interleukin-2 receptor in patients with chronic lymphoproliferative disorders of T-lymphocytes.
Zambello R; Pizzolo G; Trentin L; Agostini C; Chisesi T; Vinante F; Scarselli E; Zanotti R; Vespignani M; De Rossi G
Cancer; 1989 Nov; 64(10):2019-23. PubMed ID: 2804889
[TBL] [Abstract][Full Text] [Related]
2. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
[TBL] [Abstract][Full Text] [Related]
4. Measurement of Soluble Interleukin 2 Receptor in Sera of Adult Patients with Hematological or Solid Malignancies.
Delforge A; Bernier M; Bosmans E; Massy M; Bron D; Heyligen H; Raus J; Mendes Da Costa P; Stryckmans P
Leuk Lymphoma; 1991; 3(5-6):385-93. PubMed ID: 27467429
[TBL] [Abstract][Full Text] [Related]
5. Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease.
Yasuda N; Lai PK; Ip SH; Kung PC; Hinuma Y; Matsuoka M; Hattori T; Takatsuki K; Purtilo DT
Blood; 1988 Apr; 71(4):1021-6. PubMed ID: 2895675
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of CD8 antigen and soluble interleukin 2 receptors in patients with B cell chronic lymphocytic leukemia.
Musolino C; Di Cesare E; Alonci A; Allegra A; Orlando A; Grosso P; Squadrito G
Acta Haematol; 1991; 85(2):57-61. PubMed ID: 1902614
[TBL] [Abstract][Full Text] [Related]
7. Serum-soluble interleukin-2 receptors in B-cell lymphoproliferative malignancies.
Pavlidis NA; Manoussakis MN; Germanidis GS; Moutsopoulos HM
Med Pediatr Oncol; 1992; 20(1):26-31. PubMed ID: 1727208
[TBL] [Abstract][Full Text] [Related]
8. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G
Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of helper factors (IL-1 alpha, IL-1 beta and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and beta 2-microglobulin in patients with B-CLL and benign B lymphocytosis.
Aguilar-Santelises M; Loftenius A; Ljungh C; Svenson SB; Andersson B; Mellstedt H; Jondal M
Leuk Res; 1992; 16(6-7):607-13. PubMed ID: 1386130
[TBL] [Abstract][Full Text] [Related]
10. Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia.
Kamihira S; Atogami S; Sohda H; Momita S; Yamada Y; Tomonaga M
Cancer; 1994 Jun; 73(11):2753-8. PubMed ID: 8194016
[TBL] [Abstract][Full Text] [Related]
11. IL-2 regulation of soluble IL-2 receptor levels following thermal injury.
Teodorczyk-Injeyan JA; Sparkes BG; Lalani S; Peters WJ; Mills GB
Clin Exp Immunol; 1992 Oct; 90(1):36-42. PubMed ID: 1382903
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum levels of soluble interleukin-2 receptors in HTLV-I--associated myelopathy.
Yamaguchi K; Nishimura Y; Kiyokawa T; Takatsuki K
J Lab Clin Med; 1989 Oct; 114(4):407-10. PubMed ID: 2794753
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndrome.
Prin L; Plumas J; Gruart V; Loiseau S; Aldebert D; Ameisen JC; Vermersch A; Fenaux P; Bletry O; Capron M
Blood; 1991 Nov; 78(10):2626-32. PubMed ID: 1726707
[TBL] [Abstract][Full Text] [Related]
14. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.
Wasik MA; Sioutos N; Tuttle M; Butmarc JR; Kaplan WD; Kadin ME
Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932
[TBL] [Abstract][Full Text] [Related]
15. Increased serum soluble interleukin-2 receptor levels in dermatomyositis are associated with Th17/Treg immune imbalance.
Xie Y; Zhang T; Su R; Liu L; Jiang L; Xue H; Gao C; Li X; Wang C
Clin Exp Med; 2023 Nov; 23(7):3605-3617. PubMed ID: 37528249
[TBL] [Abstract][Full Text] [Related]
16. Soluble serum interleukin 2 receptors in patients with systemic sclerosis.
Steen VD; Engel EE; Charley MR; Medsger TA
J Rheumatol; 1996 Apr; 23(4):646-9. PubMed ID: 8730120
[TBL] [Abstract][Full Text] [Related]
17. High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia.
Semenzato G; Foa R; Agostini C; Zambello R; Trentin L; Vinante F; Benedetti F; Chilosi M; Pizzolo G
Blood; 1987 Aug; 70(2):396-400. PubMed ID: 3111560
[TBL] [Abstract][Full Text] [Related]
18. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation.
Grutters JC; Fellrath JM; Mulder L; Janssen R; van den Bosch JM; van Velzen-Blad H
Chest; 2003 Jul; 124(1):186-95. PubMed ID: 12853522
[TBL] [Abstract][Full Text] [Related]
19. [Serum level of soluble interleukin-2 receptor and T-lymphocyte subpopulations in normal pregnancy].
Liu CL; Xu HY; Liu Y
Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):518-20, 572. PubMed ID: 7835125
[TBL] [Abstract][Full Text] [Related]
20. Soluble IL-2 receptor and tumour necrosis factor-alpha in plasma of haemophilia patients infected with HIV.
Noronha IL; Daniel V; Schimpf K; Opelz G
Clin Exp Immunol; 1992 Feb; 87(2):287-92. PubMed ID: 1735193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
